JP7505831B2 - 海藻抽出物を含む高血圧症改善剤並びに同高血圧症改善剤を含む機能性食品、医薬部外品及び医薬品 - Google Patents
海藻抽出物を含む高血圧症改善剤並びに同高血圧症改善剤を含む機能性食品、医薬部外品及び医薬品 Download PDFInfo
- Publication number
- JP7505831B2 JP7505831B2 JP2023553147A JP2023553147A JP7505831B2 JP 7505831 B2 JP7505831 B2 JP 7505831B2 JP 2023553147 A JP2023553147 A JP 2023553147A JP 2023553147 A JP2023553147 A JP 2023553147A JP 7505831 B2 JP7505831 B2 JP 7505831B2
- Authority
- JP
- Japan
- Prior art keywords
- hypertension
- agent
- improving
- improving agent
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010020772 Hypertension Diseases 0.000 title claims description 81
- 239000003795 chemical substances by application Substances 0.000 title claims description 78
- 239000000284 extract Substances 0.000 title claims description 64
- 239000003814 drug Substances 0.000 title claims description 22
- 229940079593 drug Drugs 0.000 title claims description 18
- 235000013376 functional food Nutrition 0.000 title claims description 10
- 241001474374 Blennius Species 0.000 title description 51
- 239000000203 mixture Substances 0.000 claims description 52
- 230000000694 effects Effects 0.000 claims description 49
- 239000000835 fiber Substances 0.000 claims description 29
- 230000036772 blood pressure Effects 0.000 claims description 28
- 235000013325 dietary fiber Nutrition 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 28
- 239000011573 trace mineral Substances 0.000 claims description 28
- 235000013619 trace mineral Nutrition 0.000 claims description 28
- 241000206572 Rhodophyta Species 0.000 claims description 25
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- 241000195480 Fucus Species 0.000 claims description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 10
- 229940118127 fucus vesiculosus extract Drugs 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 241001428391 Corallinaceae Species 0.000 claims description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 7
- 239000011777 magnesium Substances 0.000 claims description 7
- 229910052749 magnesium Inorganic materials 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000007902 hard capsule Substances 0.000 claims description 6
- 229910052742 iron Inorganic materials 0.000 claims description 6
- 239000011574 phosphorus Substances 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- 229910052711 selenium Inorganic materials 0.000 claims description 6
- 239000011669 selenium Substances 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 5
- 239000007901 soft capsule Substances 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 235000015110 jellies Nutrition 0.000 claims description 4
- 239000008274 jelly Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 241000195879 Polytrichum Species 0.000 claims description 2
- 238000012360 testing method Methods 0.000 description 30
- 235000019645 odor Nutrition 0.000 description 20
- 239000001913 cellulose Substances 0.000 description 18
- 229920002678 cellulose Polymers 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 238000009472 formulation Methods 0.000 description 15
- 229910052500 inorganic mineral Inorganic materials 0.000 description 14
- 235000010755 mineral Nutrition 0.000 description 14
- 239000011707 mineral Substances 0.000 description 14
- 235000013305 food Nutrition 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 11
- 235000019640 taste Nutrition 0.000 description 11
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 10
- 239000011630 iodine Substances 0.000 description 10
- 229910052740 iodine Inorganic materials 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 241000227647 Fucus vesiculosus Species 0.000 description 7
- 241000199919 Phaeophyceae Species 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 230000035487 diastolic blood pressure Effects 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 230000001953 sensory effect Effects 0.000 description 7
- 230000035488 systolic blood pressure Effects 0.000 description 7
- 206010006326 Breath odour Diseases 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000002105 nanoparticle Substances 0.000 description 5
- 230000000474 nursing effect Effects 0.000 description 5
- 229940091258 selenium supplement Drugs 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 210000004211 gastric acid Anatomy 0.000 description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 4
- 229960003284 iron Drugs 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 241000195493 Cryptophyta Species 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 3
- 239000000292 calcium oxide Substances 0.000 description 3
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 3
- 235000012255 calcium oxide Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000000395 magnesium oxide Substances 0.000 description 3
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 3
- 235000012245 magnesium oxide Nutrition 0.000 description 3
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000005495 thyroid hormone Substances 0.000 description 3
- 229940036555 thyroid hormone Drugs 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000512259 Ascophyllum nodosum Species 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- 241000195628 Chlorophyta Species 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010067997 Iodine deficiency Diseases 0.000 description 2
- 241000230999 Lithothamnion Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 235000006479 iodine deficiency Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 150000002736 metal compounds Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- WCDJCWGYYQTMGO-OAHLLOKOSA-N (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-2,3,3-triiodopropanoic acid Chemical compound IC([C@](N)(C(=O)O)I)(C1=CC(I)=C(C(I)=C1)OC1=CC(I)=C(C(I)=C1)O)I WCDJCWGYYQTMGO-OAHLLOKOSA-N 0.000 description 1
- 241000271309 Aquilaria crassna Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000520028 Lamium Species 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000206608 Pyropia tenera Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 241000196252 Ulva Species 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229940095643 calcium hydroxide Drugs 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 229940087373 calcium oxide Drugs 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 229940078456 calcium stearate Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- -1 flavorings Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 208000005057 thyrotoxicosis Diseases 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
(2)前記微量元素剤は、リン、マグネシウム、マンガン、亜鉛、鉄、カルシウム、セレンから選ばれる微量元素成分のうち少なくともいずれか2以上の微量元素成分の組み合わせからなること。
(3)前記微量元素剤は、さんごも科いしも属の紅藻の灰化粉砕物であること。
(4)及び(5)前記不溶性食物繊維加工物は、繊維幅が20~80nm、繊維長が繊維幅の120倍以上である食物繊維束よりなること。
(6)剤形を粉末、細粒、顆粒、ソフトカプセル、ハードカプセル、ゼリー状、グミ状、液体又は錠剤としたこと。
(1-1.高血圧症改善剤の調製)
前述したようにヒバマタ抽出物は悪臭やえぐ味が強いため、単体では嚥下困難な成分である。本試験では、ヒバマタ抽出物の嚥下困難性が、紅藻粉末とナノ化セルロースとよりなる補助組成物の添加によりどのような影響を受けるかを試験したものである。本試験における被験製剤(食品)は、ヒバマタ抽出物、紅藻粉末、ナノ化セルロース、賦形剤(でんぷん)を添加することで調製した。被験食品は、全量1.5gの顆粒状とした。
官能試験では、健康食品等のOEM製造を行う事業所内にて長年にわたり商品試作や官能評価に携わる男女10名(20~60歳)をパネリストとして選定し、臭いや味について評価した。
次に、上述の官能試験にて評価が良好であったサンプル製剤に関し、口臭の発生を抑制できるかについて比較対象製剤と比較を行った。
(1)高血圧症改善剤含有食品の製造
次に、前述の試験におけるサンプル製剤を基本処方とし、ヒバマタ抽出物の含有量を変化させた場合の高血圧症改善効果の発現について確認を行った。試験に供した4つのサンプルの処方を表2に示す。
次に、高血圧症改善作用確認試験(ヒバマタ抽出物配合量による効果比較)を行った。
次に、補助組成物を構成する紅藻粉末やナノ化セルロースのいずれかを欠いた場合における効果の確認を行った。また本試験では、比較のために基本処方の製剤と、補助組成物を含まない製剤についても試験に供した。試験に供した4つのサンプルの処方を表3に示す。
次に、補助組成物を構成するミネラルを変化させた場合における効果の確認を行った。また本試験では、比較のために基本処方の製剤も試験に供した。試験に供した8つのサンプルの処方を図5に示し、その結果を図6に示す。
次に、補助組成物を構成する不溶性食物繊維の性状を変化させた場合、すなわち、繊維径と繊維長を変更した場合における効果の確認を行った。
Claims (9)
- 所定量のヒバマタ抽出物と、
同ヒバマタ抽出物が有する血圧改善作用を助長する補助組成物と、を含む高血圧症改善剤であって、
前記所定量は、前記高血圧症改善剤の1日あたりの摂取量中に1.5mg以上含まれる量であり、
前記補助組成物は、微量元素剤と不溶性食物繊維加工物とよりなることを特徴とする高血圧症改善剤。 - 前記微量元素剤は、リン、マグネシウム、マンガン、亜鉛、鉄、カルシウム、セレンから選ばれる微量元素成分のうち少なくともいずれか2以上の微量元素成分の組み合わせからなることを特徴とする請求項1に記載の高血圧症改善剤。
- 前記微量元素剤は、さんごも科いしも属の紅藻の灰化粉砕物であることを特徴とする請求項1に記載の高血圧症改善剤。
- 前記不溶性食物繊維加工物は、繊維幅が20~80nm、繊維長が繊維幅の120倍以上である食物繊維束よりなることを特徴とする請求項1に記載の高血圧症改善剤。
- 前記不溶性食物繊維加工物は、繊維幅が20~80nm、繊維長が繊維幅の120倍以上である食物繊維束よりなることを特徴とする請求項3に記載の高血圧症改善剤。
- 剤形を粉末、細粒、顆粒、ソフトカプセル、ハードカプセル、ゼリー状、グミ状、液体又は錠剤としたことを特徴とする請求項1~5いずれか1項に記載の高血圧症改善剤。
- 請求項1~5いずれか1項に記載の高血圧症改善剤を含むことを特徴とする機能性食品。
- 請求項1~5いずれか1項に記載の高血圧症改善剤を含むことを特徴とする医薬部外品。
- 請求項1~5いずれか1項に記載の高血圧症改善剤を含むことを特徴とする医薬品。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021202737 | 2021-12-14 | ||
JP2021202737 | 2021-12-14 | ||
PCT/JP2022/046116 WO2023112974A1 (ja) | 2021-12-14 | 2022-12-14 | 海藻抽出物を含む高血圧症改善剤並びに同高血圧症改善剤を含む機能性食品、医薬部外品及び医薬品 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2023112974A1 JPWO2023112974A1 (ja) | 2023-06-22 |
JP7505831B2 true JP7505831B2 (ja) | 2024-06-25 |
Family
ID=86774343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023553147A Active JP7505831B2 (ja) | 2021-12-14 | 2022-12-14 | 海藻抽出物を含む高血圧症改善剤並びに同高血圧症改善剤を含む機能性食品、医薬部外品及び医薬品 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP7505831B2 (ja) |
WO (1) | WO2023112974A1 (ja) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008086217A (ja) | 2006-09-29 | 2008-04-17 | Sanki Shoji Kk | 健康食品 |
CN102552471A (zh) | 2012-02-23 | 2012-07-11 | 淄博金硕生物科技有限公司 | 一种具有降压、降血脂作用的中药制剂或中药保健品 |
JP2019041661A (ja) | 2017-08-31 | 2019-03-22 | 株式会社シェフコ | 健康食品 |
JP2019058144A (ja) | 2017-09-28 | 2019-04-18 | 日華化学株式会社 | 痩身用食品及び外用剤組成物 |
JP2019070031A (ja) | 2013-03-14 | 2019-05-09 | ジェローム, ジェイ. シェンターク, | カイロミクロンへの分子の取り込みのためのコレストソーム小胞 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0716382B2 (ja) * | 1990-05-10 | 1995-03-01 | 森下仁丹株式会社 | 海藻ミネラルの製造方法 |
JP4104180B2 (ja) * | 1996-05-08 | 2008-06-18 | 一丸ファルコス株式会社 | リパーゼ活性促進剤 |
JP3247620B2 (ja) * | 1996-10-24 | 2002-01-21 | 武 小椋 | 海洋ミネラル成分からなる治療及び/または予防剤 |
JP2003079340A (ja) * | 2001-07-06 | 2003-03-18 | Tamiya Yamamura | 体質改善健康食品 |
JP4431711B2 (ja) * | 2005-04-22 | 2010-03-17 | 学校法人明治大学 | 海藻高温抽出組成物、海藻熱処理組成物及びそれらの製造方法並びに海藻高温抽出組成物又は海藻熱処理組成物を含む調味料、化粧料、食品及び健康食品 |
-
2022
- 2022-12-14 JP JP2023553147A patent/JP7505831B2/ja active Active
- 2022-12-14 WO PCT/JP2022/046116 patent/WO2023112974A1/ja active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008086217A (ja) | 2006-09-29 | 2008-04-17 | Sanki Shoji Kk | 健康食品 |
CN102552471A (zh) | 2012-02-23 | 2012-07-11 | 淄博金硕生物科技有限公司 | 一种具有降压、降血脂作用的中药制剂或中药保健品 |
JP2019070031A (ja) | 2013-03-14 | 2019-05-09 | ジェローム, ジェイ. シェンターク, | カイロミクロンへの分子の取り込みのためのコレストソーム小胞 |
JP2019041661A (ja) | 2017-08-31 | 2019-03-22 | 株式会社シェフコ | 健康食品 |
JP2019058144A (ja) | 2017-09-28 | 2019-04-18 | 日華化学株式会社 | 痩身用食品及び外用剤組成物 |
Also Published As
Publication number | Publication date |
---|---|
WO2023112974A1 (ja) | 2023-06-22 |
JPWO2023112974A1 (ja) | 2023-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8759398B2 (en) | Phosphorus binder composition for treatment of hyperphosphatemia | |
CN102626225B (zh) | 一种具有增加骨密度和保护关节功能的保健食品及其制备方法 | |
CN108783467B (zh) | 改善骨质疏松和增加骨密度的组合物及其制备方法 | |
RU2489934C2 (ru) | Способ производства биологически активных продуктов из бурых водорослей и плодов | |
KR100654904B1 (ko) | 생약 추출물을 포함하는 항염 또는 연골 재생용 조성물 | |
KR100549089B1 (ko) | 장기능 및 변비 질환 개선용 건강 기능성식품 | |
EP2106705B1 (de) | Verwendung einer Zusammensetzung, welche ein Pflanzenlektin, ein proteolytisches Enzym und eine Selenverbindung umfasst, zum Schleimhautschutz und zur Linderung anderer Symptome bei Krebspatienten | |
JP7505831B2 (ja) | 海藻抽出物を含む高血圧症改善剤並びに同高血圧症改善剤を含む機能性食品、医薬部外品及び医薬品 | |
EA027651B1 (ru) | Биологически активная добавка к пище для нормализации функции щитовидной железы | |
KR101721145B1 (ko) | L-카르니틴 구연산 마그네슘을 포함하는 배변촉진 겸용 다이어트용 식품 조성물 | |
JP2006087393A (ja) | 健康食品及び薬剤 | |
JP2007246541A (ja) | 機能性咀嚼物及びその製造方法 | |
CN107530367A (zh) | 口腔护理组合物 | |
RU2205655C1 (ru) | Средство для профилактики и лечения мочекаменной болезни | |
CN104305229B (zh) | 一种石斛膳食纤维食品及其加工方法 | |
CN101450074B (zh) | 一种明显改善胃肠道功能、防治便秘的组合物 | |
KR100654903B1 (ko) | 인진, 갈근 및 차조기를 포함하는 항염 또는 연골 재생용 조성물 | |
WO2022013581A1 (en) | Nutritional supplement, suitable for oral administration, comprising dihydromyricetin, choline and one or more vitamins with antioxidant activity, for use in the maintenance of normal liver function | |
CN113712982A (zh) | 一种预防或治疗非酒精性脂肪肝、肥胖症的组合物及制备方法和应用 | |
JP2012170342A (ja) | 味質改善剤 | |
CN117100756A (zh) | 叶绿酸组合物和其用途 | |
KR100734944B1 (ko) | 젖산칼슘 및 미강을 주재로 한 기능성 건강식품 조성물 | |
JP2008120771A (ja) | 便秘改善剤 | |
US11931393B2 (en) | Biologically active food additive for normalizing the function of the thyroid gland | |
KR101009768B1 (ko) | 맥주효모를 주성분으로 하는 건강보조식품의 제조방법 및 그 건강보조식품 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230831 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20230831 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231017 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231218 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240124 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240507 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240606 |